GlassScriptPhysician profile
Charles Jeffery Goodwin
NPI 1710001607
$8,449.48
in general payments reported to CMS, 2019-2025
38 companies · $1,283 in 2025
The $1,283 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $850 · 2020: $646 · 2021: $1,706 · 2022: $2,065 · 2023: $818 · 2024: $1,082 · 2025: $1,283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,178 · Education: $4.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,178.33 |
| Education | $4.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,570.26 | 2021-2025 | Interstim, Altaviva |
| Medtronic USA, INC. | $835.18 | 2019-2020 | |
| Teleflex LLC | $770.92 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $742.93 | 2019-2024 | Aveed, Xiaflex, Edex |
| Sumitomo Pharma America, INC. | $376.00 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $212.35 | 2019-2023 | Myrbetriq |
| Merck Sharp & Dohme LLC | $196.97 | 2021-2025 | Welireg, Keytruda, Lynparza |
| Accord Healthcare, INC. | $178.17 | 2022-2025 | |
| Palette Life Sciences, INC. | $173.25 | 2022 | |
| Abbvie INC. | $127.79 | 2021-2025 | |
| Boston Scientific Corporation | $123.06 | 2019-2025 | Spaceoar Vue System - 10ml |
| Amgen INC. | $115.10 | 2019-2021 | |
| Janssen Biotech, INC. | $98.55 | 2021-2024 | Erleada |
| Blue Earth Diagnostics | $92.30 | 2021 | |
| Bioprotect Medical, INC. | $75.74 | 2024 | Bioprotect Balloon Implant System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $75.70 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $75.55 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $73.86 | 2023-2025 | Jelmyto |
| Novartis Pharmaceuticals Corporation | $57.40 | 2020-2021 | |
| Urovant Sciences INC | $55.76 | 2022 | |
| Allergan, INC. | $41.86 | 2020-2021 | |
| Endo USA, INC. | $41.14 | 2024-2025 | Xiaflex |
| Halozyme INC | $40.23 | 2023 | |
| Siemens Medical Solutions USA, INC. | $38.88 | 2021 | |
| Calyxo, INC. | $31.74 | 2022 | |
| Antares Pharma, INC. | $28.76 | 2020-2022 | |
| Immunitybio, INC. | $28.72 | 2024-2025 | |
| Myovant Sciences INC. | $22.09 | 2022 | |
| Coloplast Corp | $20.80 | 2020 | |
| Azurity Pharmaceuticals, INC. | $20.26 | 2024 | Edarbi |
| Travere Therapeutics, INC. | $19.40 | 2019 | |
| Verity Pharmaceuticals INC. | $18.72 | 2025 | Trelstar |
| Neotract INC. | $15.01 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $14.95 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $13.94 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.40 | 2021 | |
| Ferring Pharmaceuticals INC. | $12.74 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,770.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.